Phase II clinical trial results show potential to shorten TB treatment time

by | Nov 19, 2025 | Health

Spread the love
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments